InvestorsHub Logo
Followers 48
Posts 12044
Boards Moderated 0
Alias Born 09/12/2017

Re: Monroe1 post# 221924

Thursday, 07/13/2023 7:26:06 PM

Thursday, July 13, 2023 7:26:06 PM

Post# of 233144
WHAT IS THE CASE NUMBER for the alleged case in point?

And where can this alleged filing be confirmed?---

Antonio Migliarese, CytoDyn’s interim President, commented, “The recent filing against Amarex is the next step towards holding Amarex accountable for the damages they inflicted on the Company which we will aggressively continue to pursue. This filing builds on the momentum obtained from the previous favorable ruling by the U.S. District Court for the District of Maryland in our dispute with Amarex. We are very confident in our claims, in particular, due to the results of independent and FDA audits that have been conducted as to Amarex’s services, and regulatory action taken by the FDA against Amarex. Our attorneys will be taking all steps necessary to maximize recovery from Amarex.”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News